scispace - formally typeset
R

Rivka Adler

Researcher at Technion – Israel Institute of Technology

Publications -  10
Citations -  571

Rivka Adler is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Analgesic & Placebo. The author has an hindex of 9, co-authored 10 publications receiving 535 citations.

Papers
More filters
Journal ArticleDOI

The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial

TL;DR: It is concluded that amantadine infusion is a safe and effective acute treatment for surgical neuropathic pain in cancer patients and further trials with long‐term oral or parenteral amantADine treatment should be conducted.
Journal ArticleDOI

Can personality traits and gender predict the response to morphine? An experimental cold pain study.

TL;DR: The present study confirms the existence of individual differences in response to analgesic treatment and suggests that high HA personality trait is associated with better responsiveness to morphine treatment, and that females respond better than men to both morphine and placebo.
Journal ArticleDOI

Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study.

TL;DR: Results indicate that at the doses tested, morphine and oxycodone do not produce synergistic antinociceptive effects in healthy humans exposed to the CPT.
Journal ArticleDOI

Intravenous lidocaine, amantadine, and placebo in the treatment of sciatica: a double-blind, randomized, controlled study.

TL;DR: Intravenous lidocaine rather than amantadine reduces both spontaneous and evoked sciatic pain, and all three treatments were relatively well tolerated.